Subscribe to Newsletter

Deng Hongkui

The Power List 2020 – Advanced Medicine

Changjiang Professor, the Boya Chair Professor, and Director of the Institute of Stem Cell Research at Peking University

In 1989, Deng Hongkui left China for the US, working on HIV at New York University before switching to stem cells – eventually becoming research director of the stem cell company ViaCell in Cambridge, Massachusetts. He then went back to China after being awarded the prestigious Changjiang Professorship. In 2017, he and Chen Hu engineered resistance to HIV in mice using CRISPR gene editing, and for the first time used the technique on an AIDS patient – demonstrating the safety of CRISPR for humans.

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine